NZ729735A - Biosensor based on gβυ-interacting proteins to monitor g-protein activation - Google Patents

Biosensor based on gβυ-interacting proteins to monitor g-protein activation

Info

Publication number
NZ729735A
NZ729735A NZ729735A NZ72973515A NZ729735A NZ 729735 A NZ729735 A NZ 729735A NZ 729735 A NZ729735 A NZ 729735A NZ 72973515 A NZ72973515 A NZ 72973515A NZ 729735 A NZ729735 A NZ 729735A
Authority
NZ
New Zealand
Prior art keywords
protein
biosensors
gβυ
monitor
interacting proteins
Prior art date
Application number
NZ729735A
Other languages
English (en)
Inventor
Michel Bouvier
Gouill Christian Le
Mireille Hogue
Viktoriya Lukasheva
Original Assignee
Univ Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montreal filed Critical Univ Montreal
Publication of NZ729735A publication Critical patent/NZ729735A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4719—G-proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ729735A 2014-10-14 2015-10-14 Biosensor based on gβυ-interacting proteins to monitor g-protein activation NZ729735A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462063622P 2014-10-14 2014-10-14
PCT/CA2015/051032 WO2016058094A1 (en) 2014-10-14 2015-10-14 BIOSENSOR BASED ON GβΥ-INTERACTING PROTEINS TO MONITOR G-PROTEIN ACTIVATION

Publications (1)

Publication Number Publication Date
NZ729735A true NZ729735A (en) 2023-05-26

Family

ID=55745919

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ729735A NZ729735A (en) 2014-10-14 2015-10-14 Biosensor based on gβυ-interacting proteins to monitor g-protein activation

Country Status (13)

Country Link
US (1) US10877036B2 (enExample)
EP (1) EP3207052B1 (enExample)
JP (1) JP6932636B2 (enExample)
CN (1) CN107074926B (enExample)
AU (1) AU2015333543B2 (enExample)
CA (1) CA2963579C (enExample)
DK (1) DK3207052T3 (enExample)
ES (1) ES2832331T3 (enExample)
IL (1) IL250949B (enExample)
NZ (1) NZ729735A (enExample)
PL (1) PL3207052T3 (enExample)
SG (1) SG11201701895VA (enExample)
WO (1) WO2016058094A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019062744A1 (zh) * 2017-09-27 2019-04-04 北京大学 融合多肽
WO2019076262A1 (zh) * 2017-10-18 2019-04-25 深圳华大生命科学研究院 检测目标分子化合物的生物感应器及包含该生物感应器的系统
CN111164226A (zh) * 2017-10-18 2020-05-15 蒙特利尔大学 评估g蛋白活化的系统和方法
US12360111B2 (en) * 2018-12-04 2025-07-15 The University Of North Carolina At Chapel Hill G protein-coupled receptor screening systems
FR3092172B1 (fr) * 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
CN110981943B (zh) * 2019-12-02 2021-08-03 清华大学 多肽及其在制备药物中的用途和药物
KR102778534B1 (ko) 2022-10-07 2025-03-07 성균관대학교산학협력단 G 단백질 알파 서브유닛의 알파-헬리컬 도메인의 실시간 구조 변화 확인 방법 및 시스템

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003087134A2 (en) * 2002-04-12 2003-10-23 Schering Corporation G-protein coupled receptor ligands and methods
US20050042720A1 (en) 2003-04-24 2005-02-24 7Tm Pharma A/S Novel promiscuous G alpha protein mutants and their use
US7488583B2 (en) 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
WO2005121755A1 (en) 2004-06-14 2005-12-22 Commonwealth Scientific And Industrial Research Organisation Cell free g-protein coupled receptor and ligand assay
GB0822259D0 (en) * 2008-12-05 2009-01-14 Ge Healthcare Uk Ltd Methods for testing binding of a ligand to a G protein- coupled receptor
SG172321A1 (en) * 2009-01-29 2011-07-28 Commw Scient Ind Res Org Measuring g protein coupled receptor activation
GB0905419D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Uk Ltd Methods for testing ligand binding to G protein-coupled receptors
BR112013011164A2 (pt) 2010-11-11 2016-08-23 Ube Industries recipiente para solução eletrolítica não aquosa, solução eletrolítica não aquosa para colocar no recipiente e método para armazenar a solução eletrolítica não aquosa
WO2012098413A1 (en) * 2011-01-21 2012-07-26 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
US10324085B2 (en) * 2013-12-23 2019-06-18 Université de Montréal Systems and methods for the monitoring of protein complex formation in cells

Also Published As

Publication number Publication date
SG11201701895VA (en) 2017-04-27
CN107074926B (zh) 2021-09-21
IL250949B (en) 2021-07-29
JP6932636B2 (ja) 2021-09-08
US10877036B2 (en) 2020-12-29
PL3207052T3 (pl) 2021-02-08
JP2017536104A (ja) 2017-12-07
US20170234870A1 (en) 2017-08-17
EP3207052A4 (en) 2018-04-25
WO2016058094A1 (en) 2016-04-21
EP3207052B1 (en) 2020-09-30
CA2963579A1 (en) 2016-04-21
CA2963579C (en) 2023-10-31
AU2015333543B2 (en) 2021-03-04
CN107074926A (zh) 2017-08-18
IL250949A0 (en) 2017-04-30
EP3207052A1 (en) 2017-08-23
ES2832331T3 (es) 2021-06-10
DK3207052T3 (da) 2020-11-16
AU2015333543A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
NZ729735A (en) Biosensor based on gβυ-interacting proteins to monitor g-protein activation
PH12020550205A1 (en) IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
MX2025005375A (es) Variantes de desoxirribonucleasa (dnasa)
ZA202211577B (en) Multivalent and multispecific 41bb-binding fusion proteins
WO2016033331A8 (en) Conditionally active chimeric antigen receptors for modified t-cells
EP4219562A3 (en) Antibody constructs for flt3 and cd3
EP3950941A3 (en) Dnase polypeptide variants
MX383142B (es) Composiciones que comprenden polipéptidos que tienen actividad xilanasa y polipéptidos que tienen actividad arabinofuranosidasa.
MX2021008367A (es) Constructos de anticuerpos para cdh19 y cd3.
ZA201607061B (en) Transgene genetic tags and methods of use
WO2015015448A3 (en) Engineered polypeptide conjugates using transglutaminase
MX2018000948A (es) Proteinas de fusion que se unen a gitir multivalentes y multiespecificas.
PH12018500216B1 (en) Antibody constructs for cd70 and cd3
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
MA40390A (fr) Procédés d'analyse impliquant des nanoparticules dissociables
WO2015140638A8 (en) Glycosylated vegf decoy receptor fusion protein
WO2015195769A3 (en) Optogenetic probes for measuring membrane potential
CY1124727T1 (el) Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων
EP3593133A4 (en) LC-MS / MS-BASED PROCESSES FOR CHARACTERIZING PROTEIN
NZ731491A (en) Cd83 binding proteins and uses thereof
EP3134390A4 (en) Small molecule inhibitors of g protein coupled receptor 6 kinase polypeptides
NZ746677A (en) Novel alpha-1-microglobulin derived proteins and their use
WO2013188635A3 (en) Novel methods of identifying proteins via n-terminal tagging and selective pull-down
SG10201806532RA (en) Proteins targeting orthologs
EP3153520A4 (en) Peptide tags for marking proteins by fusion, and antibodies for the detection thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2024 BY IRG

Effective date: 20230903

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2025 BY IRG

Effective date: 20240926

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2026 BY INTERNATIONAL RENEWALS GROUP

Effective date: 20251004